How can you create a solid and long market exclusivity for your new medicines? How do you keep the competition at bay to get more than just your investment back? Welcome to a seminar where you will learn more about how you best combine strategies for IP protection and regulatory exclusivity.
The key to competitiveness, license revenues and new investments lies in a strong patent portfolio that protects even when market entry is far away. By combining this with various types of regulatory exclusivity when it's time to put the product on the market, you can maximize your protection.
- What are the critical decisions, and when do you have to take them?
- How do you prepare to compete in the major jurisdictions of the EU, US and Asia?
- What should you focus on to minimize the risk of losing market share to others?
In this breakfast seminar, experts will discuss relevant issues with everyone who develops pharmaceutical products.
- Marie Gårdmark, regulatory expert at RegSmart Life Science
- Joanna Applequist, European Patent Attorney at AWA
- Louise Jonshammar, lawyer at AWA
The speakers will share their experience and insights from working many years in the industry. During the seminar there will also be opportunities to ask your questions.
When: Thursday 14 March at 08.30-09.45. Breakfast is served from 08:00.
Where: The Park, Forskaren, Hagaesplanaden 1, Stockholm.
The seminar is in English. The number of seats is limited.
In case of a no-show without cancellation, we charge a no-show fee of 200 SEK. We do this to reduce any food waste and to be able to offer a seat to somebody else when our events are fully booked. To cancel, email info@ssci.se.
Register on this link no later than March 10 >>
This seminar is a cooperation between Stockholm Science City, AWA, Regsmart Life Science and The Park.
